MedPath

Amdipharm Limited

🇸🇪Sweden
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

62

CIMA_AEMPS:28
CANADA:15
NMPA:2
+2 more agencies

Drug Approvals

Fusidic Acid Eye Drops

Product Name
夫司名
Approval Number
国药准字HJ20171044
Approval Date
May 6, 2022
NMPA

Roxithromycin Tablets

Product Name
罗力得
Approval Number
国药准字HJ20170250
Approval Date
Jul 7, 2020
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.